Number of the records: 1
NADPH-oxidázy
SYS d019255 LBL 00000cx--j2200000---45-- 005 20240119201335.4 100 $a 19960610asloy0103----ba0 152 $b mesh 250 $a NADPH-oxidázy $x AD $x AE $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2018 (1997) $8 eng 300 1-
$a NADH, NADPH Oxidoreductases (1979-1996) $8 eng 300 1-
$a NADP (1972-1980) $8 eng 300 1-
$a Oxidoreductases (1972-1978) $8 eng 330 1-
$a A family of membrane-associated flavoprotein NADPH-dependent oxidoreductases that catalyze the univalent reduction of OXYGEN to create SUPEROXIDES. Structurally, they are characterized by six N-terminal transmembrane ALPHA-HELICES, a FLAVIN-ADENINE DINUCLEOTIDE (FAD)-binding region, and a C-terminal NADPH-binding region. They are expressed primarily by EPITHELIAL CELLS in gut, kidney, colon, and smooth muscle tissues, as well as GRANULOCYTES and function to transfer electrons across membranes to molecular oxygen. Defects in the production of superoxide ions by some NADPH oxidases result in GRANULOMATOUS DISEASE, CHRONIC. $8 eng 450 $a NADPH Oxidase $5 e $8 eng 450 $a NADPH oxidáza $5 e $8 slo 450 $a NAD(P)H oxidázy $5 e $8 slo 450 $a NAD(P)H oxidáza $5 e $8 slo 450 $a proteíny NOX $5 e $8 slo 550 $3 sllk_un_auth*d006105 $Y Granulomatous Disease, Chronic $5 F $a choroba granulomatózna chronická 686 $a D08.811.682.608.575 686 $a D12.776.331.894 686 $a D12.776.543.653 750 $a NADPH Oxidases $8 eng 801 -0
$a US $b DNLM $c 19960610 801 -2
$a SK $b BA006 $c 20010712 801 -2
$a SK $b BA006 $c 20180807 801 -2
$a SK $b BA006 $c 20190103 980 $x M
Number of the records: 1